8-139732009-G-A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6BP7BS1BS2

The NM_001160372.4(TRAPPC9):​c.3249C>T​(p.Phe1083Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00781 in 1,596,098 control chromosomes in the GnomAD database, including 64 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0050 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0081 ( 61 hom. )

Consequence

TRAPPC9
NM_001160372.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 1.51

Publications

1 publications found
Variant links:
Genes affected
TRAPPC9 (HGNC:30832): (trafficking protein particle complex subunit 9) This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
TRAPPC9 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal recessive 13
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • intellectual disability-obesity-brain malformations-facial dysmorphism syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 8-139732009-G-A is Benign according to our data. Variant chr8-139732009-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 130632.
BP7
Synonymous conserved (PhyloP=1.51 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.005 (762/152352) while in subpopulation NFE AF = 0.00747 (508/68032). AF 95% confidence interval is 0.00693. There are 3 homozygotes in GnomAd4. There are 343 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAPPC9NM_001160372.4 linkc.3249C>T p.Phe1083Phe synonymous_variant Exon 22 of 23 ENST00000438773.4 NP_001153844.1 Q96Q05-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAPPC9ENST00000438773.4 linkc.3249C>T p.Phe1083Phe synonymous_variant Exon 22 of 23 1 NM_001160372.4 ENSP00000405060.3 Q96Q05-1

Frequencies

GnomAD3 genomes
AF:
0.00501
AC:
762
AN:
152234
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00176
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.00697
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00747
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00617
AC:
1351
AN:
218814
AF XY:
0.00642
show subpopulations
Gnomad AFR exome
AF:
0.00159
Gnomad AMR exome
AF:
0.00469
Gnomad ASJ exome
AF:
0.00480
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00818
Gnomad NFE exome
AF:
0.00814
Gnomad OTH exome
AF:
0.00691
GnomAD4 exome
AF:
0.00810
AC:
11701
AN:
1443746
Hom.:
61
Cov.:
32
AF XY:
0.00801
AC XY:
5738
AN XY:
716254
show subpopulations
African (AFR)
AF:
0.00115
AC:
38
AN:
33158
American (AMR)
AF:
0.00481
AC:
204
AN:
42392
Ashkenazi Jewish (ASJ)
AF:
0.00471
AC:
121
AN:
25714
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38852
South Asian (SAS)
AF:
0.00610
AC:
508
AN:
83238
European-Finnish (FIN)
AF:
0.00899
AC:
467
AN:
51920
Middle Eastern (MID)
AF:
0.00261
AC:
15
AN:
5744
European-Non Finnish (NFE)
AF:
0.00895
AC:
9874
AN:
1103066
Other (OTH)
AF:
0.00794
AC:
474
AN:
59662
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
708
1416
2124
2832
3540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00500
AC:
762
AN:
152352
Hom.:
3
Cov.:
33
AF XY:
0.00460
AC XY:
343
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00176
AC:
73
AN:
41590
American (AMR)
AF:
0.00327
AC:
50
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4826
European-Finnish (FIN)
AF:
0.00697
AC:
74
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00747
AC:
508
AN:
68032
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00586
Hom.:
1
Bravo
AF:
0.00492
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 01, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRAPPC9: BP4, BP7, BS2 -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual Disability, Recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 17, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 03, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

TRAPPC9-related disorder Benign:1
May 14, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
9.2
DANN
Benign
0.60
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112551069; hg19: chr8-140744252; API